glp 1 agonist renal failure GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Current GLP-1 receptor agonists and

But since peptide coupling agents are described as immune sensitizers, it stands to reason that the risk even if its small exists for everyone.18 Copper peptide uglies Anecdotal reports suggest that some people may experience worsened skin aging, instead of anti-aging, after using products with GHK-Cu, a rare concern dubbed copper peptide uglies. While this isnt necessarily a safety issue, it is a (again, rare) potential negative effect of using copper peptide products

Persistent fatigue should be assessed by a healthcare provider to rule out other causes

Morton points to retatrutide, a weekly injection from Eli Lilly currently in clinical development for obesity and type 2 diabetes, as an example

It inhibits the production of melanin, the pigment responsible for skin coloration, leading to a brighter and more even complexion

FREE MONTHLY NEWSLETTER Want the Latest Peptide Updates

Potential Hair & Scalp Benefits 1